Axonics® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year® 2020 Award Winner for Orange CountyBusiness Wire • 10/07/20
Axonics® Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim IIBusiness Wire • 10/05/20
Axonics® Receives Health Canada Approval of Next Generation Implantable NeurostimulatorBusiness Wire • 09/21/20
Axonics® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year® 2020 Award Finalist for Orange CountyBusiness Wire • 09/16/20
Axonics® to Host Presentation of Full 2-Year Clinical Results from ARTISAN-SNM Pivotal Study on September 9Business Wire • 09/02/20
Axonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
Axonics® Announces 2-Year Topline Clinical Results from ARTISAN-SNM Pivotal StudyBusiness Wire • 07/27/20
Axonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/09/20
Axonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/05/20
Axonics Modulation Technologies (AXNX) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/04/20
Axonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/15/19